Evidence map›Paper›PMID 31759979›Full record

ArticleBiochemical pharmacology2020

Regulation of beta adrenoceptor-mediated myocardial contraction and calcium dynamics by the G protein-coupled estrogen receptor 1.

Victoria Whitcomb, Eric Wauson, Daniel Christian, Sarah Clayton, Jennifer Giles, Quang-Kim Tran

Open access · greenAbstract read
In one paragraph

Article in Biochemical pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. GPER limits adverse changes to CaFrontiers in physiology · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Female Heart Health: Is GPER the Missing Link?Frontiers in endocrinology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Victoria WhitcombDepartment of Physiology and Pharmacology, Des Moines University Osteopathic Medical Center, 3200 Grand Avenue, Des Moines, IA 50312, United States.
Eric WausonDepartment of Physiology and Pharmacology, Des Moines University Osteopathic Medical Center, 3200 Grand Avenue, Des Moines, IA 50312, United States.
Daniel ChristianDepartment of Physiology and Pharmacology, Des Moines University Osteopathic Medical Center, 3200 Grand Avenue, Des Moines, IA 50312, United States.
Sarah ClaytonDepartment of Physiology and Pharmacology, Des Moines University Osteopathic Medical Center, 3200 Grand Avenue, Des Moines, IA 50312, United States.
Jennifer GilesDepartment of Physiology and Pharmacology, Des Moines University Osteopathic Medical Center, 3200 Grand Avenue, Des Moines, IA 50312, United States.
Quang-Kim TranDepartment of Physiology and Pharmacology, Des Moines University Osteopathic Medical Center, 3200 Grand Avenue, Des Moines, IA 50312, United States. Electronic address: kim.tran@dmu.edu.
Des Moines University Osteopathic Medical Center · US

Funding

Regulation of GPER-mediated Signaling in the Vasculature by CalmodulinR15HL112184 · NHLBI · DES MOINES UNIV OSTEOPATHIC MEDICAL CTR · PI TRAN, KIM · 2012 to 2012
$362k
NHLBI NIH HHS R15 HL112184
6 · The paper itself

Abstract

The G protein-coupled estrogen receptor 1 (GPER) produces cardioprotective effects. However, the underlying mechanisms are not well understood. We aimed to investigate the role of GPER in β adrenoceptor-mediated cardiac contraction and myocardial signaling. In anesthetized animals, intrajugular administration of isoproterenol produces a rapid and sustained rise in left ventricular pressure (LVP) and increases ectopic contractions. Administration of the GPER agonist G-1 during the plateau phase of isoproterenol-induced LVP increase rapidly restores LVP to baseline levels and reduces the frequency of ectopic contractions. In freshly isolated cardiomyocytes, isoproterenol potentiates electrically induced peak currents of L-type Ca

Indexed as

Adrenergic beta-AntagonistsAnimalsBenzodioxolesCalciumCalcium Channels, L-TypeCells, CulturedCyclopentanesEstrogen Receptor alphaIsoproterenolKineticsMaleMiceMyocardial ContractionMyocardiumMyocytes, CardiacPhosphorylation1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanoneAdrenergic beta-AntagonistsBenzodioxolesCalciumCalcium Channels, L-TypeCyclopentanesEstrogen Receptor alphaG36 compoundIsoproterenolL-type calcium channel alpha(1C)QuinolinesReceptors, Adrenergic, betaReceptors, G-Protein-CoupledCalciumCa(v)1.2 channelContractionGPERβ(1) adrenoceptor

Identifiers

PMID31759979
PMCPMC6952073
OpenAlexW2990891882

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.